FORMULATION AND CHARACTERIZATION OF EUDRAGIT RS 100 NANOSUSPENSION FOR OCULAR DELIVERY OF INDOMETHACIN

Registration ID: IJNRD_181592

Published ID: IJNRD2205180

DOI: Click Here to Get

SRASHTI KATIYAR , Dr. PANKAJ MISHRA , JEEVAN CHANDRA PANDEY

Introduction, Drug Profile, Experimental Investigation, Drug and Polymer Profile, Summary.

ABSTRACT Several colloidal drug delivery systems were designed to obtain a control release for ophthalmic applications were investigated. These are composed of a polymeric support with or without drug. The drug was normally incorporated as a dispersion or solution in the polymeric support. The main objective of the nano suspension is to increase the contact time of the preparation with conjunctiva tissues so as to ensure a Sustained / Controlled release suited for the topical or systemic treatment. However the details about the preparations and their model of construction are given in many literatures but no specific guideline are mentioned. In the present work, a revival attempts has made us to investigate Indomethacin ocular nano suspension utilizing Eudragit RS 100 as drug reservoir membrane and rate controlling component and its possible utilization in designing and evaluating it for ophthalmic use. All formulations were subjected to various evaluation parameters like identification and compatibility studies of drug and polymer using IR spectrometer and were evaluated for parameters like pH, particle size analysis, drug entrapment efficiency, rheological studies; rabbit eye irritation, in vitro release studies, in vivo drug studies and stability studies. The uniformity of the nano suspension revealed that the drug was uniformly distributed throughout the nano suspension. Increase in the polymer ratio increases the entrapment efficiency of drug which observed by entrapment efficiency studies. Further future work can be progressed to establish the therapeutic utility of these systems by pharmacokinetic and pharmacodynamic studies in human beings. The different Novel Technology can be adopted in the formulation for ophthalmic nano suspensions and thereby investigate their effect on release pattern.

Published Paper   E-Certificate

SRASHTI KATIYAR, Dr. PANKAJ MISHRA, & JEEVAN CHANDRA PANDEY (May-2022). FORMULATION AND CHARACTERIZATION OF EUDRAGIT RS 100 NANOSUSPENSION FOR OCULAR DELIVERY OF INDOMETHACIN . INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 7(5), 1340-1352. https://ijnrd.org/papers/IJNRD2205180.pdf

Volume 7 Issue 5, May-2022

Pages : 1340-1352

Paper Reg. ID: IJNRD_181592

Published Paper Id: IJNRD2205180

Downloads: 000121979

Research Area: Pharmacy

Country: Bareilly, UTTAR PRADESH, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2205180.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2205180

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details